The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Low-Dose Naltrexone for Treating MS Symptoms
Verywell Health
05 January 2020
https://www.verywellhealth.com/naltrexone-for-ms-2440888
Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment
BMJ Case Reports
January 2018
https://casereports.bmj.com/content/2018/bcr-2017-221405
Leonard Weinstock, MD - POTS and Mast Cell Activation Syndromes (2017 Conference) (LDN, low dose naltrexone)
Dr Leonard Weinstock is from St Louis in Missouri and helps patients with GI Issues and other autoimmune conditions.
Jill Brook MA - 16th May 2018 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Jill Brook, MA shares her Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.
Dickson Chemist developed a new formulation of LDN which will hopefully improve the outcomes for patients. This new formulation is a more concentrated liquid in the form of drops which are administered under the tongue and absorbed directly from the mucosal lining of the mouth. This sublingual route produces a more rapid absorption bypassing the liver and digestive tract. There are several potential advantages to this, the drug may be more effective and will not be affected by the presence of food stuffs or the hostile environment of the gut.